Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
21.52
0.36 (1.70%)
At close: Jun 25, 2025, 3:59 PM
21.68
0.72%
After-hours: Jun 25, 2025, 04:08 PM EDT
1.70% (1D)
| Bid | 19.72 |
| Market Cap | 1.24B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -94.83M |
| EPS (ttm) | -1.92 |
| PE Ratio (ttm) | -11.21 |
| Forward PE | -7.73 |
| Analyst | Buy |
| Ask | 25.92 |
| Volume | 421,650 |
| Avg. Volume (20D) | 445,141 |
| Open | 20.93 |
| Previous Close | 21.16 |
| Day's Range | 20.49 - 21.66 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 0.95 |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+11.44%
Enliven Therapeutics shares are trading higher. Th...
Unlock content with
Pro Subscription
1 month ago
-10.41%
Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.